MPLA preconditioning protects against lethal radiation-combined burn injury with attenuation of KC/CXCL1-associated vascular leakage in mice
BACKGROUND: Radiation-combined burn injury (RCB), defined as concurrent irradiation and burn injury, is expected to be common in radiological or nuclear mass-casualty events and can be highly lethal. The mechanisms underlying the irradiation-burn interaction remain poorly understood, particularly whether it amplifies capillary leak and inflammatory mediator responses to drive early lethality. We examined whether repeated low-dose monophosphoryl lipid A (MPLA) preconditioning modulates this response and whether KC/CXCL1 contributes to vascular leakage. METHODS: Male C57BL/6J mice underwent 6 Gy whole-body irradiation followed 1 h later by a 20% total body surface area full-thickness burn. MPLA (10 µg/mouse) or vehicle was administered intraperitoneally on days -4 and -3. We assessed 30-day survival, hemoconcentration, intravascular FITC-albumin retention, intestinal barrier endpoints, and cytokine/chemokine responses. A separate exploratory experiment evaluated pre-irradiation anti-KC/CXCL1 antibody treatment. RESULTS: Neither injury alone was lethal, whereas vehicle-treated RCB mice had 90% mortality (9 of 10 mice). Seven of these deaths occurred at 24-48 h after RCB. MPLA preconditioning increased 30-day survival from 10% to 80% (p = 0.0003) and eliminated deaths within 48 h. RCB induced hemoconcentration and tended to reduce FITC-albumin retention. Compared with vehicle-treated RCB mice, MPLA-preconditioned RCB mice had less hemoconcentration, significantly higher FITC-albumin retention, and lower mesenteric lymph node bacterial burden. MPLA preconditioning suppressed KC/CXCL1, which showed the largest absolute increase among measured cytokines/chemokines at 6 h. Anti-KC/CXCL1 antibody treatment significantly increased FITC-albumin retention at 6 h (p = 0.038). CONCLUSIONS: MPLA preconditioning improved survival after RCB. It may attenuate early inflammatory and vascular abnormalities. Exploratory antibody-treatment findings suggest a possible contribution of KC/CXCL1 to early vascular albumin leakage, warranting further validation.
Authors
- Kazuma Mori (ORCID: https://orcid.org/0000-0002-0212-1039)
- Bradley M. Kearney (ORCID: https://orcid.org/0000-0003-3037-0945)
- Harry Scherthan
- Ryohei Suematsu (ORCID: https://orcid.org/0000-0002-5038-874X)
- Azusa Kato (ORCID: https://orcid.org/0000-0001-9976-2248)
- Kohei Yamada (ORCID: https://orcid.org/0000-0003-4449-1545)
- Hiroyuki Nakashima (ORCID: https://orcid.org/0000-0001-6066-3031)
- Manabu Kinoshita (ORCID: https://orcid.org/0000-0002-2750-3084)
- Masahiro Nakashima (ORCID: https://orcid.org/0000-0003-4385-5802)
- Jéssica Müller
- Masafumi Saito
- Kazuya Yoshimoto
- Vijay K Singh
Institutions
- Uniformed Services University of the Health Sciences (US)
- Universität Ulm (DE)
- National Defense Medical College Hospital (JP)
- Institut für Radiobiologie der Bundeswehr (DE)
- National Defense Medical College (JP)
Publication Details
- Journal
- Shock
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1097/shk.0000000000002964
- Primary Topic
- Effects of Radiation Exposure
- Type
- article
- Field-Weighted Citation Impact
- 0.00